Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Potent inhibitors of aspartate N-acetyl-transferase for the treatment of Canavan disease

Potent inhibitors of aspartate N-acetyl-transferase for the treatment of Canavan disease

US Patent 11186541 · Granted Nov 30, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Potent phthalate inhibitors of aspartate N-acetyltransferase and selective aspar2019
Potent phthalate inhibitors of aspartate N-acetyltransferase and selective aspar2019
Potent phthalate inhibitors of aspartate N-acetyltransferase and selective aspar2019
Potent phthalate inhibitors of aspartate N-acetyltransferase and selective aspar2019
Truncated aspartase enzyme derivatives and uses thereof2000
Truncated aspartase enzyme derivatives and uses thereof1999